Automated description from the Alliance of Genome Resources (Release 3.0)
Predicted to have transforming growth factor beta receptor binding activity. Predicted to be involved in several processes, including Mullerian duct regression; preantral ovarian follicle growth; and regulation of gene expression. Localizes to cytoplasm. Human ortholog(s) of this gene implicated in ovarian carcinoma; persistent Mullerian duct syndrome; and sex development disorder. Is expressed in several structures, including early conceptus; genitourinary system; liver; lung; and spleen. Orthologous to human AMH (anti-Mullerian hormone).